Evidence map›Paper›PMID 37888347›Full record

ArticleGels (Basel, Switzerland)2023

A Study of the Properties of Scaffolds for Bone Regeneration Modified with Gel-like Coatings of Chitosan and Folic Acid.

Aleksandra Bandzerewicz, Kamila Godzieba, Kamil Wierzchowski, Maciej Pilarek, Agnieszka Gadomska-Gajadhur

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Hybrid Poly(Lactic)-Chitosan Scaffold Intensifying In Situ Bioprocessing ofInternational journal of molecular sciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleksandra BandzerewiczFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.ORCID 0000-0002-6283-1913
Kamila GodziebaFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.
Kamil WierzchowskiFaculty of Chemical and Process Engineering, Warsaw University of Technology, 00-645 Warsaw, Poland.ORCID 0000-0002-7718-0033
Maciej PilarekFaculty of Chemical and Process Engineering, Warsaw University of Technology, 00-645 Warsaw, Poland.ORCID 0000-0002-8489-0842
Agnieszka Gadomska-GajadhurFaculty of Chemistry, Warsaw University of Technology, 00-664 Warsaw, Poland.ORCID 0000-0001-7686-1745

Funding

National Centre for Research and Development (LIDER/4/0010/L-11/19/NCBR/2020)
6 · The paper itself

Abstract

The research has been conducted to obtain scaffolds for cancellous bone regeneration. Polylactide scaffolds were made by the phase inversion method with a freeze-extraction variant, including gelling polylactide in its non-solvent. Substitutes made of polylactide are hydrophobic, which limits cell adhesion. For this reason, the scaffolds were modified using chitosan and folic acid by forming gel-like coatings on the surface. The modification aimed to improve the material's surface properties and increase cell adhesion. Analyses of obtained scaffolds confirmed the effectiveness of performed changes. The presence of chitosan and folic acid was confirmed in the modified scaffolds, while all scaffolds retained high open porosity, which is essential for proper cell growth inside the scaffold and the free flow of nutrients. Hydrostatic weighing showed that the scaffolds have high mass absorbability, allowing them to be saturated with biological fluids. There were also cytotoxicity tests performed on 24 h extracts of the materials obtained, which indicated a lack of cytotoxic effect.

Indexed as

bone regenerationchitosanfolic acidgel coatingspolylactidepolymer gellingscaffoldtissue engineering

Identifiers

PMID37888347
PMCPMC10606535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.